Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Massachusetts General Hospital
mi
from
Boston, MA
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Mount Sinai School of Medicine Division of Vascular Surgery
mi
from
New York, NY
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Mount Sinai School of Medicine Division of Vascular Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
University Hospitals of Cleveland / Case Medical Center
mi
from
Cleveland, OH
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
University Hospitals of Cleveland / Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
University of Utah-Vascular Surgery Division
mi
from
Salt Lake City, UT
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
University of Utah-Vascular Surgery Division
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Swedish Medical Center
mi
from
Seattle, WA
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Comprehensive Cardiovascular Care St. Luke's Medical Center
mi
from
Milwaukee, WI
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Comprehensive Cardiovascular Care St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
Status: Enrolling
Updated:  7/26/2011
University of Connecticut Health Center
mi
from
Farmington, CT
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
Status: Enrolling
Updated: 7/26/2011
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)
A Clinical Evaluation of Dual Antiplatelet Therapy Duration Following Treatment With the Medtronic Endeavor Zotarolimus-eluting Coronary Stent
Status: Enrolling
Updated:  7/26/2011
Scripps Clinic
mi
from
La Jolla, CA
Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)
A Clinical Evaluation of Dual Antiplatelet Therapy Duration Following Treatment With the Medtronic Endeavor Zotarolimus-eluting Coronary Stent
Status: Enrolling
Updated: 7/26/2011
Scripps Clinic
mi
from
La Jolla, CA
Click here to add this to my saved trials
Canola Oil Multicentre Intervention Trial (COMIT)
Canola and Flax Oils in Modulation of Vascular Function and Biomarkers of Cardiovascular Disease Risk
Status: Enrolling
Updated:  8/1/2011
Penn State University
mi
from
Hershey, PA
Canola Oil Multicentre Intervention Trial (COMIT)
Canola and Flax Oils in Modulation of Vascular Function and Biomarkers of Cardiovascular Disease Risk
Status: Enrolling
Updated: 8/1/2011
Penn State University
mi
from
Hershey, PA
Click here to add this to my saved trials
Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE)
Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double Blind Placebo Controlled Trial
Status: Enrolling
Updated:  8/15/2011
Ohio State University
mi
from
Columbus, OH
Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE)
Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double Blind Placebo Controlled Trial
Status: Enrolling
Updated: 8/15/2011
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Relation of Diet to Heart Disease Risk Factors in Children
Relation of Diet to Heart Disease Risk Factors in Children
Status: Enrolling
Updated:  8/15/2011
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Relation of Diet to Heart Disease Risk Factors in Children
Relation of Diet to Heart Disease Risk Factors in Children
Status: Enrolling
Updated: 8/15/2011
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease
A Prospective Evaluation of a Medication Therapy Management Clinic Versus Usual Medical Care in Patients Post Acute Coronary Syndrome: The MUMPS Study
Status: Enrolling
Updated:  8/31/2011
VA Tennessee Valley Healthcare System
mi
from
Nashville, TN
Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease
A Prospective Evaluation of a Medication Therapy Management Clinic Versus Usual Medical Care in Patients Post Acute Coronary Syndrome: The MUMPS Study
Status: Enrolling
Updated: 8/31/2011
VA Tennessee Valley Healthcare System
mi
from
Nashville, TN
Click here to add this to my saved trials
Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Status: Enrolling
Updated:  9/20/2011
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Status: Enrolling
Updated: 9/20/2011
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
Peroxisome Proliferator-activated Receptor-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
Status: Enrolling
Updated:  10/6/2011
University of Michigan Research Center
mi
from
Ann Arbor, MI
PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
Peroxisome Proliferator-activated Receptor-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
Status: Enrolling
Updated: 10/6/2011
University of Michigan Research Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Status: Enrolling
Updated:  10/11/2011
Georgetown University Hospital
mi
from
Washington,
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Status: Enrolling
Updated: 10/11/2011
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
STATUS-PCI: Stable Angina Therapy With Angiomax® or Unfractionated Heparin for patientS Undergoing Percutaneous Coronary Intervention
Status: Enrolling
Updated:  11/2/2011
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
STATUS-PCI: Stable Angina Therapy With Angiomax® or Unfractionated Heparin for patientS Undergoing Percutaneous Coronary Intervention
Status: Enrolling
Updated: 11/2/2011
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Reduce Cardiovascular Risk in Women Through Tai Chi Intervention
Exploring the Effects of Tai Chi on Cardiometabolic Risk in Women
Status: Enrolling
Updated:  11/3/2011
Virginia Commonwealth University
mi
from
Richmond, VA
Reduce Cardiovascular Risk in Women Through Tai Chi Intervention
Exploring the Effects of Tai Chi on Cardiometabolic Risk in Women
Status: Enrolling
Updated: 11/3/2011
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Aspirin Responsiveness in Women With Coronary Artery Disease
Aspirin Responsiveness in Women With Coronary Artery Disease
Status: Enrolling
Updated:  1/16/2012
The Cardiac Center at Creighton University
mi
from
Omaha, NE
Aspirin Responsiveness in Women With Coronary Artery Disease
Aspirin Responsiveness in Women With Coronary Artery Disease
Status: Enrolling
Updated: 1/16/2012
The Cardiac Center at Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Lovaza's Effect on Clopidogrel in a Neuro Population
The Effects of Polyunsaturated Omega-3 Fatty Acids (Lovaza) on Patients Taking Clopidogrel +/- Aspirin Who Have Suffered an Ischemic Stroke/TIA and/or Are Candidates for Neuroendovascular Stenting.
Status: Enrolling
Updated:  2/1/2012
Millmore Fillmore Gates Hospital
mi
from
Buffalo, NY
Lovaza's Effect on Clopidogrel in a Neuro Population
The Effects of Polyunsaturated Omega-3 Fatty Acids (Lovaza) on Patients Taking Clopidogrel +/- Aspirin Who Have Suffered an Ischemic Stroke/TIA and/or Are Candidates for Neuroendovascular Stenting.
Status: Enrolling
Updated: 2/1/2012
Millmore Fillmore Gates Hospital
mi
from
Buffalo, NY
Click here to add this to my saved trials
Intracardiac T-wave Alternans and Ischemia
Intracardiac T-wave Alternans and Ischemia During Percutaneous Coronary Interventions
Status: Enrolling
Updated:  2/8/2012
Columbia University Medical Center
mi
from
New York, NY
Intracardiac T-wave Alternans and Ischemia
Intracardiac T-wave Alternans and Ischemia During Percutaneous Coronary Interventions
Status: Enrolling
Updated: 2/8/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Optimized Biventricular Pacing Allograft Recipients
Optimized Biventricular Pacing in Allograft Recipients
Status: Enrolling
Updated:  2/14/2012
Columbia University Medial Center
mi
from
New York, NY
Optimized Biventricular Pacing Allograft Recipients
Optimized Biventricular Pacing in Allograft Recipients
Status: Enrolling
Updated: 2/14/2012
Columbia University Medial Center
mi
from
New York, NY
Click here to add this to my saved trials
Vasoprotective Activities of Low-Fat Milk in Individuals With Metabolic Syndrome
Vasoprotective Activities of Low-Fat Milk in Individuals With Metabolic Syndrome
Status: Enrolling
Updated:  2/14/2012
University of Connecticut
mi
from
Storrs, CT
Vasoprotective Activities of Low-Fat Milk in Individuals With Metabolic Syndrome
Vasoprotective Activities of Low-Fat Milk in Individuals With Metabolic Syndrome
Status: Enrolling
Updated: 2/14/2012
University of Connecticut
mi
from
Storrs, CT
Click here to add this to my saved trials
REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts
Status: Enrolling
Updated:  2/15/2012
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts
Status: Enrolling
Updated: 2/15/2012
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Stress Reduction Training to Improve Sleep Quality, Stress Physiology & Cardiovascular Disease (CVD) Risk Markers
The Effect of Mindfulness-Based Stress Reduction on Sleep Quality, Stress Physiology & CVD Risk
Status: Enrolling
Updated:  2/20/2012
Duke Integrative Medicine
mi
from
Durham, NC
Stress Reduction Training to Improve Sleep Quality, Stress Physiology & Cardiovascular Disease (CVD) Risk Markers
The Effect of Mindfulness-Based Stress Reduction on Sleep Quality, Stress Physiology & CVD Risk
Status: Enrolling
Updated: 2/20/2012
Duke Integrative Medicine
mi
from
Durham, NC
Click here to add this to my saved trials
Hydrogen Sulfide and Peripheral Arterial Disease
Hydrogen Sulfide and Peripheral Arterial Disease
Status: Enrolling
Updated:  2/21/2012
LSUHSC Shreveport
mi
from
Shreveport, LA
Hydrogen Sulfide and Peripheral Arterial Disease
Hydrogen Sulfide and Peripheral Arterial Disease
Status: Enrolling
Updated: 2/21/2012
LSUHSC Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials
Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia
Allogeneic,Unrelated, Menstrual Derived, Mesenchymal Stem Cell-Like, Endometrial Cells; Administered Intramuscular
Status: Enrolling
Updated:  3/18/2012
Indiana University School of Medicine
mi
from
Indianapolis, IN
Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia
Allogeneic,Unrelated, Menstrual Derived, Mesenchymal Stem Cell-Like, Endometrial Cells; Administered Intramuscular
Status: Enrolling
Updated: 3/18/2012
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pomegranate and Hemodialysis Pilot Trial
A Pilot Trial Assessing the Effect of Pomegranate Juice and Extract on Biomarkers of Oxidative Stress, Systemic Inflammation, and Monocyte Function in Hemodialysis Patients
Status: Enrolling
Updated:  3/22/2012
Northwest Kidney Centers
mi
from
Seattle, WA
Pomegranate and Hemodialysis Pilot Trial
A Pilot Trial Assessing the Effect of Pomegranate Juice and Extract on Biomarkers of Oxidative Stress, Systemic Inflammation, and Monocyte Function in Hemodialysis Patients
Status: Enrolling
Updated: 3/22/2012
Northwest Kidney Centers
mi
from
Seattle, WA
Click here to add this to my saved trials
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Status: Enrolling
Updated:  3/28/2012
Minneapolis Heart Institute Foundation
mi
from
Minneapolis, MN
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Status: Enrolling
Updated: 3/28/2012
Minneapolis Heart Institute Foundation
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Status: Enrolling
Updated:  3/28/2012
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Status: Enrolling
Updated: 3/28/2012
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Status: Enrolling
Updated:  3/28/2012
University of Virginia
mi
from
Charlottesville, VA
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Status: Enrolling
Updated: 3/28/2012
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated:  3/29/2012
Univ. of Colorado at Denver and Health Sciences Center
mi
from
Aurora, CO
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated: 3/29/2012
Univ. of Colorado at Denver and Health Sciences Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated:  3/29/2012
Emory University
mi
from
Atlanta, GA
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated: 3/29/2012
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated:  3/29/2012
University of Iowa
mi
from
Iowa City, IA
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated: 3/29/2012
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated:  3/29/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated: 3/29/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated:  3/29/2012
University of Cincinnati
mi
from
Cincinnati, OH
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated: 3/29/2012
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated:  3/29/2012
University Hospitals
mi
from
Cleveland, OH
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated: 3/29/2012
University Hospitals
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated:  3/29/2012
The Cleveland Clinic
mi
from
Cleveland, OH
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated: 3/29/2012
The Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated:  3/29/2012
Univ of Pennsylvania
mi
from
Philadelphia, PA
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated: 3/29/2012
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated:  3/29/2012
Vanderbilt Heart and Vascular Institute
mi
from
Nashville, TN
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC
Status: Enrolling
Updated: 3/29/2012
Vanderbilt Heart and Vascular Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy. (YELLOW Trial)
Status: Enrolling
Updated:  3/29/2012
Mount Sinai Hospital
mi
from
New York, NY
Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy. (YELLOW Trial)
Status: Enrolling
Updated: 3/29/2012
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Acetaminophen for Oxidative Stress After Cardiopulmonary Bypass
Does Preoperative Acetaminophen Reduce Biochemical Markers of Oxidative Stress From Cardiopulmonary Bypass?
Status: Enrolling
Updated:  4/11/2012
Vanderbilt University
mi
from
Nashville, TN
Acetaminophen for Oxidative Stress After Cardiopulmonary Bypass
Does Preoperative Acetaminophen Reduce Biochemical Markers of Oxidative Stress From Cardiopulmonary Bypass?
Status: Enrolling
Updated: 4/11/2012
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting
Randomized, Double-Blind, Placebo-controlled Trial of 6 vs. 12 Months Clopidogrel Therapy After Implantation of a Drug-Eluting Stent
Status: Enrolling
Updated:  4/19/2012
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting
Randomized, Double-Blind, Placebo-controlled Trial of 6 vs. 12 Months Clopidogrel Therapy After Implantation of a Drug-Eluting Stent
Status: Enrolling
Updated: 4/19/2012
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
An Epidemiological Study of the Prevalence of Pre-Diabetes and Diabetes Among Air Force Personnel Who Fail the Air Force Physical Fitness Test at Nellis AFB, NV in 2011.
An Epidemiological Study of the Prevalence of Pre-Diabetes and Diabetes Among Air Force Personnel Who Fail the Air Force Physical Fitness Test at Nellis AFB, NV in 2011.
Status: Enrolling
Updated:  4/19/2012
Mike O'Callaghan Federal Hospital/Nellis Air Force Base
mi
from
Las Vegas, NV
An Epidemiological Study of the Prevalence of Pre-Diabetes and Diabetes Among Air Force Personnel Who Fail the Air Force Physical Fitness Test at Nellis AFB, NV in 2011.
An Epidemiological Study of the Prevalence of Pre-Diabetes and Diabetes Among Air Force Personnel Who Fail the Air Force Physical Fitness Test at Nellis AFB, NV in 2011.
Status: Enrolling
Updated: 4/19/2012
Mike O'Callaghan Federal Hospital/Nellis Air Force Base
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Registry Experience at the Washington Hospital Center, DES - Endeavor for Myocardial Infarction
REWARDS-EMI (Registry Experience at the Washington Hospital Center, DES - Endeavor for Myocardial Infarction)
Status: Enrolling
Updated:  4/23/2012
MedStar Washington Hospital Center
mi
from
Washington,
Registry Experience at the Washington Hospital Center, DES - Endeavor for Myocardial Infarction
REWARDS-EMI (Registry Experience at the Washington Hospital Center, DES - Endeavor for Myocardial Infarction)
Status: Enrolling
Updated: 4/23/2012
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Promus - Registry Experience at the Washington Hospital Center, Drug-eluting Stent (DES)
P-REWARDS (Promus - Registry Experience at the Washington Hospital Center, DES)
Status: Enrolling
Updated:  4/23/2012
MedStar Washington Hospital Center
mi
from
Washington,
Promus - Registry Experience at the Washington Hospital Center, Drug-eluting Stent (DES)
P-REWARDS (Promus - Registry Experience at the Washington Hospital Center, DES)
Status: Enrolling
Updated: 4/23/2012
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Registry Experience at the Washington Hospital Center, DES - Xience V
REWARDS (Registry Experience at the Washington Hospital Center, DES - Xience V)
Status: Enrolling
Updated:  4/23/2012
MedStar Washington Hospital Center
mi
from
Washington,
Registry Experience at the Washington Hospital Center, DES - Xience V
REWARDS (Registry Experience at the Washington Hospital Center, DES - Xience V)
Status: Enrolling
Updated: 4/23/2012
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
A Trial of Tadalafil and Glycemic Traits
Phase 3 Randomized Trial of Tadalafil and Glycemic Traits
Status: Enrolling
Updated:  4/26/2012
Massachusetts General Hospital
mi
from
Boston, MA
A Trial of Tadalafil and Glycemic Traits
Phase 3 Randomized Trial of Tadalafil and Glycemic Traits
Status: Enrolling
Updated: 4/26/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Improving Care for Patients With High Blood Pressure
Heart Healthy Lenoir: Improving Care for Patients With High Blood Pressure
Status: Enrolling
Updated:  5/3/2012
Kinston Enterprise Center - Study Office
mi
from
Kinston, NC
Improving Care for Patients With High Blood Pressure
Heart Healthy Lenoir: Improving Care for Patients With High Blood Pressure
Status: Enrolling
Updated: 5/3/2012
Kinston Enterprise Center - Study Office
mi
from
Kinston, NC
Click here to add this to my saved trials
Protein Intake, Nutrition and Cardiovascular Diseases in Stage V CKD
Protein Intake, Nutrition and Cardiovascular Disease in Stage V CKD on Hemodialysis
Status: Enrolling
Updated:  5/10/2012
Vanderbilt University Medical Centet
mi
from
Nashville, TN
Protein Intake, Nutrition and Cardiovascular Diseases in Stage V CKD
Protein Intake, Nutrition and Cardiovascular Disease in Stage V CKD on Hemodialysis
Status: Enrolling
Updated: 5/10/2012
Vanderbilt University Medical Centet
mi
from
Nashville, TN
Click here to add this to my saved trials